Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|April 11, 2019
Increase of invasive meningococcal serogroup W disease in Europe, 2013 to 2017Manuel Krone, Steve Gray, Raquel Abad, et al.
The Pediatric Infectious Disease Journal|May 23, 2013
A multi-country evaluation of Neisseria meningitidis serogroup B factor H-binding proteins and implications for vaccine coverage in different age groupsSusan K Hoiseth, Ellen Murphy, Lubomira Andrew, et al.
Emerging Infectious Diseases|April 21, 2022
Pertactin-Deficient Bordetella pertussis with Unusual Mechanism of Pertactin Disruption, Spain, 1986-2018Alba Mir-Cros, Albert Moreno-Mingorance, M Teresa Martín-Gómez, et al.
Vaccine|January 22, 2019
Genetic Meningococcal Antigen Typing System (gMATS): A genotyping tool that predicts 4CMenB strain coverage worldwideAlessandro Muzzi, Alessandro Brozzi, Laura Serino, et al.
Antimicrobial Agents and Chemotherapy|July 8, 2010
Multicenter study for defining the breakpoint for rifampin resistance in Neisseria meningitidis by rpoB sequencingMuhamed-Kheir Taha, Sara Thulin Hedberg, Marek Szatanik, et al.
Mbio|March 15, 2018
Predicting the Susceptibility of Meningococcal Serogroup B Isolates to Bactericidal Antibodies Elicited by Bivalent rLP2086, a Novel Prophylactic VaccineLisa K McNeil, Robert G K Donald, Alexey Gribenko, et al.
The Lancet. Infectious Diseases|February 19, 2013
Predicted strain coverage of a meningococcal multicomponent vaccine (4CMenB) in Europe: a qualitative and quantitative assessmentUlrich Vogel, Muhamed-Kheir Taha, Julio A Vazquez, et al.
Clinical and Vaccine Immunology : CVI|August 10, 2012
Interlaboratory standardization of the sandwich enzyme-linked immunosorbent assay designed for MATS, a rapid, reproducible method for estimating the strain coverage of investigational vaccinesBrian D Plikaytis, Maria Stella, Giuseppe Boccadifuoco, et al.
BMC Infectious Diseases|March 27, 2019
Ten years of external quality assessment (EQA) of Neisseria gonorrhoeae antimicrobial susceptibility testing in Europe elucidate high reliability of dataMichelle J Cole, Nerteley Quaye, Susanne Jacobsson, et al.
The New England Journal of Medicine|February 1, 2023
Effectiveness of a Meningococcal Group B Vaccine (4CMenB) in ChildrenJesús Castilla, Manuel García Cenoz, Raquel Abad, et al.
Pageof 6